Structure

Physi-Chem Properties

Molecular Weight:  318.22
Volume:  347.268
LogP:  3.568
LogD:  2.919
LogS:  -3.526
# Rotatable Bonds:  2
TPSA:  60.69
# H-Bond Aceptor:  3
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.782
Synthetic Accessibility Score:  4.225
Fsp3:  0.7
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.651
MDCK Permeability:  1.3916985153628048e-05
Pgp-inhibitor:  0.024
Pgp-substrate:  0.3
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.817
30% Bioavailability (F30%):  0.891

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.357
Plasma Protein Binding (PPB):  94.19969940185547%
Volume Distribution (VD):  2.577
Pgp-substrate:  8.021097183227539%

ADMET: Metabolism

CYP1A2-inhibitor:  0.054
CYP1A2-substrate:  0.816
CYP2C19-inhibitor:  0.04
CYP2C19-substrate:  0.898
CYP2C9-inhibitor:  0.127
CYP2C9-substrate:  0.495
CYP2D6-inhibitor:  0.054
CYP2D6-substrate:  0.219
CYP3A4-inhibitor:  0.806
CYP3A4-substrate:  0.535

ADMET: Excretion

Clearance (CL):  13.631
Half-life (T1/2):  0.303

ADMET: Toxicity

hERG Blockers:  0.033
Human Hepatotoxicity (H-HT):  0.174
Drug-inuced Liver Injury (DILI):  0.026
AMES Toxicity:  0.044
Rat Oral Acute Toxicity:  0.259
Maximum Recommended Daily Dose:  0.183
Skin Sensitization:  0.851
Carcinogencity:  0.108
Eye Corrosion:  0.003
Eye Irritation:  0.031
Respiratory Toxicity:  0.742

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469663

Natural Product ID:  NPC469663
Common Name*:   Macrophynin E
IUPAC Name:   (4bS,8S,8aR,9R)-8-(hydroxymethyl)-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-1,9-diol
Synonyms:   Macrophynin E
Standard InCHIKey:  COPQDCGDRVTCTF-GSEOLPGOSA-N
Standard InCHI:  InChI=1S/C20H30O3/c1-12(2)13-6-7-15-14(17(13)23)10-16(22)18-19(3,11-21)8-5-9-20(15,18)4/h6-7,12,16,18,21-23H,5,8-11H2,1-4H3/t16-,18+,19-,20-/m1/s1
SMILES:  CC(C)C1=C(C2=C(C=C1)C3(CCCC(C3C(C2)O)(C)CO)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1097039
PubChem CID:   46887227
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota feces n.a. n.a. PMID[20402524]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 40000.0 nM PMID[488246]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 40000.0 nM PMID[488246]
NPT15 Cell Line Jurkat Homo sapiens IC50 > 40000.0 nM PMID[488246]
NPT466 Cell Line U-937 Homo sapiens IC50 > 40000.0 nM PMID[488246]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469663 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC92
0.9636 High Similarity NPC219112
0.9636 High Similarity NPC38893
0.9636 High Similarity NPC308311
0.9636 High Similarity NPC477137
0.9636 High Similarity NPC308828
0.9554 High Similarity NPC469644
0.955 High Similarity NPC477136
0.9545 High Similarity NPC192948
0.9545 High Similarity NPC147179
0.9545 High Similarity NPC35797
0.9464 High Similarity NPC469609
0.9464 High Similarity NPC471671
0.9455 High Similarity NPC268160
0.9375 High Similarity NPC304510
0.9375 High Similarity NPC172219
0.9266 High Similarity NPC132720
0.9182 High Similarity NPC176279
0.9182 High Similarity NPC260323
0.913 High Similarity NPC260832
0.913 High Similarity NPC135467
0.9123 High Similarity NPC154030
0.9107 High Similarity NPC195922
0.9099 High Similarity NPC228425
0.9099 High Similarity NPC250323
0.9091 High Similarity NPC141782
0.9027 High Similarity NPC469719
0.9009 High Similarity NPC77772
0.8991 High Similarity NPC472979
0.8991 High Similarity NPC27252
0.8983 High Similarity NPC471187
0.8981 High Similarity NPC243601
0.8957 High Similarity NPC164649
0.8957 High Similarity NPC48342
0.8947 High Similarity NPC471668
0.8929 High Similarity NPC46940
0.8919 High Similarity NPC13482
0.8909 High Similarity NPC149455
0.8909 High Similarity NPC64642
0.8909 High Similarity NPC472982
0.8908 High Similarity NPC181334
0.8898 High Similarity NPC471794
0.8889 High Similarity NPC328504
0.8879 High Similarity NPC151197
0.885 High Similarity NPC715
0.8839 High Similarity NPC470770
0.8839 High Similarity NPC95716
0.8839 High Similarity NPC266937
0.8818 High Similarity NPC151477
0.8818 High Similarity NPC472980
0.8807 High Similarity NPC117115
0.8783 High Similarity NPC257540
0.8783 High Similarity NPC141001
0.8783 High Similarity NPC474358
0.8783 High Similarity NPC137496
0.8783 High Similarity NPC247858
0.8783 High Similarity NPC474387
0.8783 High Similarity NPC154511
0.8772 High Similarity NPC471534
0.8761 High Similarity NPC302371
0.8761 High Similarity NPC177962
0.8761 High Similarity NPC62867
0.8739 High Similarity NPC11250
0.8739 High Similarity NPC11554
0.8739 High Similarity NPC152946
0.8739 High Similarity NPC478058
0.8739 High Similarity NPC71094
0.8718 High Similarity NPC323074
0.8718 High Similarity NPC126002
0.8718 High Similarity NPC93071
0.8716 High Similarity NPC475225
0.8707 High Similarity NPC16030
0.8689 High Similarity NPC471077
0.8678 High Similarity NPC87985
0.8678 High Similarity NPC76119
0.8678 High Similarity NPC4286
0.8673 High Similarity NPC322753
0.8667 High Similarity NPC198014
0.8661 High Similarity NPC58865
0.8655 High Similarity NPC142198
0.8655 High Similarity NPC253627
0.8655 High Similarity NPC77569
0.8649 High Similarity NPC320439
0.8644 High Similarity NPC477037
0.8644 High Similarity NPC318581
0.8644 High Similarity NPC325544
0.8624 High Similarity NPC471228
0.8624 High Similarity NPC235762
0.8624 High Similarity NPC19856
0.8607 High Similarity NPC321822
0.8607 High Similarity NPC325294
0.8571 High Similarity NPC32322
0.8571 High Similarity NPC259703
0.8571 High Similarity NPC262365
0.856 High Similarity NPC476847
0.856 High Similarity NPC312341
0.8559 High Similarity NPC21594
0.8547 High Similarity NPC299180
0.8545 High Similarity NPC238696
0.8525 High Similarity NPC137750
0.8525 High Similarity NPC124030
0.8522 High Similarity NPC317869
0.8509 High Similarity NPC151537
0.85 High Similarity NPC162935
0.85 High Similarity NPC249340
0.8496 Intermediate Similarity NPC314187
0.8492 Intermediate Similarity NPC85595
0.8487 Intermediate Similarity NPC68339
0.8482 Intermediate Similarity NPC66834
0.848 Intermediate Similarity NPC196193
0.8475 Intermediate Similarity NPC206
0.8468 Intermediate Similarity NPC47284
0.8455 Intermediate Similarity NPC100414
0.8455 Intermediate Similarity NPC43000
0.844 Intermediate Similarity NPC174911
0.8435 Intermediate Similarity NPC471179
0.843 Intermediate Similarity NPC176208
0.843 Intermediate Similarity NPC121168
0.843 Intermediate Similarity NPC321402
0.8421 Intermediate Similarity NPC296683
0.8417 Intermediate Similarity NPC241001
0.8413 Intermediate Similarity NPC471851
0.8393 Intermediate Similarity NPC271274
0.8393 Intermediate Similarity NPC53740
0.8387 Intermediate Similarity NPC186889
0.8387 Intermediate Similarity NPC476536
0.8387 Intermediate Similarity NPC108164
0.8378 Intermediate Similarity NPC272029
0.8378 Intermediate Similarity NPC323810
0.8376 Intermediate Similarity NPC474486
0.8376 Intermediate Similarity NPC84999
0.8376 Intermediate Similarity NPC246760
0.8364 Intermediate Similarity NPC252105
0.8364 Intermediate Similarity NPC51015
0.8362 Intermediate Similarity NPC322239
0.8349 Intermediate Similarity NPC33675
0.8349 Intermediate Similarity NPC299762
0.8348 Intermediate Similarity NPC308689
0.8348 Intermediate Similarity NPC469912
0.8347 Intermediate Similarity NPC475166
0.8347 Intermediate Similarity NPC154696
0.8346 Intermediate Similarity NPC59239
0.8333 Intermediate Similarity NPC99795
0.8333 Intermediate Similarity NPC324602
0.8306 Intermediate Similarity NPC71610
0.8305 Intermediate Similarity NPC472862
0.8304 Intermediate Similarity NPC138942
0.8291 Intermediate Similarity NPC249270
0.8291 Intermediate Similarity NPC12656
0.8288 Intermediate Similarity NPC269212
0.8281 Intermediate Similarity NPC227719
0.8281 Intermediate Similarity NPC78307
0.8276 Intermediate Similarity NPC228452
0.8273 Intermediate Similarity NPC72729
0.8273 Intermediate Similarity NPC211885
0.8273 Intermediate Similarity NPC294741
0.8273 Intermediate Similarity NPC225506
0.8268 Intermediate Similarity NPC78575
0.8264 Intermediate Similarity NPC129176
0.8261 Intermediate Similarity NPC44732
0.8257 Intermediate Similarity NPC79241
0.8257 Intermediate Similarity NPC6597
0.8257 Intermediate Similarity NPC474073
0.825 Intermediate Similarity NPC42657
0.824 Intermediate Similarity NPC30491
0.824 Intermediate Similarity NPC262936
0.8235 Intermediate Similarity NPC320864
0.8231 Intermediate Similarity NPC68292
0.823 Intermediate Similarity NPC155072
0.8217 Intermediate Similarity NPC202225
0.8214 Intermediate Similarity NPC288411
0.8205 Intermediate Similarity NPC319803
0.8203 Intermediate Similarity NPC289624
0.8203 Intermediate Similarity NPC27578
0.8203 Intermediate Similarity NPC321086
0.8197 Intermediate Similarity NPC474115
0.819 Intermediate Similarity NPC471188
0.8189 Intermediate Similarity NPC472793
0.8182 Intermediate Similarity NPC103916
0.8182 Intermediate Similarity NPC122005
0.8182 Intermediate Similarity NPC478121
0.8182 Intermediate Similarity NPC128723
0.8182 Intermediate Similarity NPC318552
0.8182 Intermediate Similarity NPC99734
0.8182 Intermediate Similarity NPC190501
0.8182 Intermediate Similarity NPC252821
0.8175 Intermediate Similarity NPC201069
0.8167 Intermediate Similarity NPC48781
0.8167 Intermediate Similarity NPC9592
0.8165 Intermediate Similarity NPC312132
0.8165 Intermediate Similarity NPC259512
0.816 Intermediate Similarity NPC470724
0.8158 Intermediate Similarity NPC474352
0.8151 Intermediate Similarity NPC312105
0.8148 Intermediate Similarity NPC289769
0.8142 Intermediate Similarity NPC219286
0.8142 Intermediate Similarity NPC471350
0.8142 Intermediate Similarity NPC99557
0.8136 Intermediate Similarity NPC473137
0.8136 Intermediate Similarity NPC107240

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469663 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8957 High Similarity NPD3091 Approved
0.8761 High Similarity NPD7635 Approved
0.8655 High Similarity NPD3092 Approved
0.8649 High Similarity NPD2342 Discontinued
0.8525 High Similarity NPD3094 Phase 2
0.8487 Intermediate Similarity NPD3095 Discontinued
0.8182 Intermediate Similarity NPD3019 Approved
0.8182 Intermediate Similarity NPD4059 Approved
0.8165 Intermediate Similarity NPD288 Approved
0.8108 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD5736 Approved
0.8073 Intermediate Similarity NPD844 Approved
0.8073 Intermediate Similarity NPD1809 Phase 2
0.8056 Intermediate Similarity NPD845 Approved
0.8033 Intermediate Similarity NPD2932 Approved
0.8018 Intermediate Similarity NPD3020 Approved
0.7965 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7899 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7863 Intermediate Similarity NPD4750 Phase 3
0.7846 Intermediate Similarity NPD6663 Approved
0.7818 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD4097 Suspended
0.7786 Intermediate Similarity NPD3620 Phase 2
0.7786 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD2859 Approved
0.7748 Intermediate Similarity NPD2860 Approved
0.7742 Intermediate Similarity NPD2286 Discontinued
0.7731 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD3021 Approved
0.7712 Intermediate Similarity NPD3022 Approved
0.7705 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD7743 Approved
0.7687 Intermediate Similarity NPD7742 Approved
0.7661 Intermediate Similarity NPD4093 Discontinued
0.7658 Intermediate Similarity NPD2933 Approved
0.7658 Intermediate Similarity NPD2934 Approved
0.7652 Intermediate Similarity NPD4140 Approved
0.7638 Intermediate Similarity NPD5327 Phase 3
0.76 Intermediate Similarity NPD4626 Approved
0.76 Intermediate Similarity NPD1751 Approved
0.7597 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD4624 Approved
0.7594 Intermediate Similarity NPD5735 Approved
0.7541 Intermediate Similarity NPD497 Approved
0.754 Intermediate Similarity NPD3023 Approved
0.754 Intermediate Similarity NPD3026 Approved
0.752 Intermediate Similarity NPD3025 Approved
0.752 Intermediate Similarity NPD3024 Approved
0.75 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD2605 Approved
0.7481 Intermediate Similarity NPD2606 Approved
0.7464 Intermediate Similarity NPD3638 Discontinued
0.7459 Intermediate Similarity NPD495 Approved
0.7459 Intermediate Similarity NPD498 Approved
0.7459 Intermediate Similarity NPD496 Approved
0.7442 Intermediate Similarity NPD6696 Suspended
0.7424 Intermediate Similarity NPD4625 Phase 3
0.7424 Intermediate Similarity NPD5155 Approved
0.7424 Intermediate Similarity NPD5156 Approved
0.7419 Intermediate Similarity NPD7340 Approved
0.7417 Intermediate Similarity NPD1792 Phase 2
0.7407 Intermediate Similarity NPD6353 Approved
0.7405 Intermediate Similarity NPD3635 Approved
0.7405 Intermediate Similarity NPD3636 Approved
0.7405 Intermediate Similarity NPD2861 Phase 2
0.7405 Intermediate Similarity NPD3637 Approved
0.7388 Intermediate Similarity NPD4060 Phase 1
0.7381 Intermediate Similarity NPD5691 Approved
0.7357 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD3594 Approved
0.7348 Intermediate Similarity NPD3595 Approved
0.7344 Intermediate Similarity NPD1201 Approved
0.7338 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7328 Intermediate Similarity NPD2194 Approved
0.7328 Intermediate Similarity NPD2195 Approved
0.7323 Intermediate Similarity NPD4589 Approved
0.7317 Intermediate Similarity NPD1398 Phase 1
0.7302 Intermediate Similarity NPD7741 Discontinued
0.7265 Intermediate Similarity NPD846 Approved
0.7265 Intermediate Similarity NPD940 Approved
0.7239 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD6674 Discontinued
0.7203 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6671 Approved
0.7188 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD2229 Approved
0.7177 Intermediate Similarity NPD2234 Approved
0.7177 Intermediate Similarity NPD2228 Approved
0.7176 Intermediate Similarity NPD1283 Approved
0.7167 Intermediate Similarity NPD1444 Approved
0.7167 Intermediate Similarity NPD1445 Approved
0.7165 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD7330 Discontinued
0.7165 Intermediate Similarity NPD5303 Approved
0.7165 Intermediate Similarity NPD5304 Approved
0.7163 Intermediate Similarity NPD7003 Approved
0.7154 Intermediate Similarity NPD2232 Approved
0.7154 Intermediate Similarity NPD2233 Approved
0.7154 Intermediate Similarity NPD2230 Approved
0.7133 Intermediate Similarity NPD7041 Phase 2
0.7133 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD2238 Phase 2
0.7122 Intermediate Similarity NPD5405 Approved
0.7122 Intermediate Similarity NPD5406 Approved
0.7122 Intermediate Similarity NPD5404 Approved
0.7122 Intermediate Similarity NPD5408 Approved
0.7121 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD1470 Approved
0.712 Intermediate Similarity NPD5951 Approved
0.7109 Intermediate Similarity NPD1651 Approved
0.7101 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD4749 Approved
0.709 Intermediate Similarity NPD4908 Phase 1
0.7083 Intermediate Similarity NPD3645 Discontinued
0.7071 Intermediate Similarity NPD4725 Approved
0.7071 Intermediate Similarity NPD4721 Approved
0.7071 Intermediate Similarity NPD4726 Approved
0.7054 Intermediate Similarity NPD5125 Phase 3
0.7054 Intermediate Similarity NPD5126 Approved
0.7054 Intermediate Similarity NPD7725 Approved
0.705 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD8166 Discontinued
0.7034 Intermediate Similarity NPD1242 Phase 1
0.7 Intermediate Similarity NPD111 Approved
0.6984 Remote Similarity NPD9618 Approved
0.6984 Remote Similarity NPD9614 Approved
0.6984 Remote Similarity NPD2629 Approved
0.6977 Remote Similarity NPD4235 Clinical (unspecified phase)
0.6977 Remote Similarity NPD4196 Clinical (unspecified phase)
0.697 Remote Similarity NPD4659 Approved
0.6957 Remote Similarity NPD3657 Discovery
0.695 Remote Similarity NPD5763 Approved
0.695 Remote Similarity NPD5762 Approved
0.695 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6947 Remote Similarity NPD1281 Approved
0.6947 Remote Similarity NPD1611 Approved
0.6947 Remote Similarity NPD1610 Phase 2
0.694 Remote Similarity NPD6584 Phase 3
0.6929 Remote Similarity NPD4198 Discontinued
0.6929 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6929 Remote Similarity NPD7157 Approved
0.6918 Remote Similarity NPD6273 Approved
0.6917 Remote Similarity NPD8651 Approved
0.6912 Remote Similarity NPD3027 Phase 3
0.6905 Remote Similarity NPD5283 Phase 1
0.6901 Remote Similarity NPD7037 Approved
0.6899 Remote Similarity NPD2227 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7390 Discontinued
0.6894 Remote Similarity NPD2231 Phase 2
0.6894 Remote Similarity NPD2235 Phase 2
0.6892 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6889 Remote Similarity NPD4208 Discontinued
0.6884 Remote Similarity NPD2979 Phase 3
0.6879 Remote Similarity NPD6100 Approved
0.6879 Remote Similarity NPD6099 Approved
0.6875 Remote Similarity NPD8131 Suspended
0.6875 Remote Similarity NPD7636 Approved
0.6871 Remote Similarity NPD5699 Approved
0.687 Remote Similarity NPD3143 Discontinued
0.6866 Remote Similarity NPD4103 Phase 2
0.6866 Remote Similarity NPD4104 Clinical (unspecified phase)
0.6861 Remote Similarity NPD6812 Clinical (unspecified phase)
0.685 Remote Similarity NPD1791 Approved
0.685 Remote Similarity NPD1793 Approved
0.6849 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6842 Remote Similarity NPD1669 Approved
0.6822 Remote Similarity NPD9615 Approved
0.6822 Remote Similarity NPD9616 Approved
0.6822 Remote Similarity NPD9613 Approved
0.6812 Remote Similarity NPD6405 Approved
0.6812 Remote Similarity NPD6407 Approved
0.6812 Remote Similarity NPD8032 Phase 2
0.6809 Remote Similarity NPD1753 Discontinued
0.6803 Remote Similarity NPD6090 Discontinued
0.6797 Remote Similarity NPD709 Approved
0.6794 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6794 Remote Similarity NPD1778 Approved
0.6788 Remote Similarity NPD7008 Discontinued
0.6786 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6786 Remote Similarity NPD2157 Approved
0.6783 Remote Similarity NPD4256 Phase 2
0.6783 Remote Similarity NPD4257 Approved
0.6781 Remote Similarity NPD2421 Approved
0.6781 Remote Similarity NPD2420 Approved
0.6777 Remote Similarity NPD9500 Approved
0.6774 Remote Similarity NPD2684 Approved
0.6769 Remote Similarity NPD316 Approved
0.6767 Remote Similarity NPD3070 Discontinued
0.6763 Remote Similarity NPD3109 Approved
0.6763 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6763 Remote Similarity NPD3110 Approved
0.6763 Remote Similarity NPD1613 Approved
0.675 Remote Similarity NPD3028 Approved
0.6748 Remote Similarity NPD968 Approved
0.6746 Remote Similarity NPD228 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data